QiLaser part of stem cell study for heart failure in Armenia

The IRB approved stem cell clinical study in Armenia with 10 patients will test the use of the QiLaser in combination with cord blood stem cells anticipated to improve heart health in people with heart failure. All the patients were selected for their condition of severe heart failure with an Ejection Fraction (EF) of less than 30%. The clinical study, conducted at the Erebouni Medical Center in Yerevan, Armenia is the first of its kind to study how QiLaser guided stem cells may improve heart health.”